Literature DB >> 21805091

OETMAP: a new feature encoding scheme for MHC class I binding prediction.

Murat Gök1, Ahmet Turan Özcerit.   

Abstract

Deciphering the understanding of T cell epitopes is critical for vaccine development. As recognition of specific peptides bound to Major histocompatibility complex (MHC) class I molecules, cytotoxic T cells are activated. This is the major step to initiate of immune system response. Knowledge of the MHC specificity will enlighten the way of diagnosis, treatment of pathogens as well as peptide vaccine development. So far, a number of methods have been developed to predict MHC/peptide binding. In this article, a novel feature amino acid encoding scheme is proposed to predict MHC/peptide complexes. In the proposed method, we have combined orthonormal encoding (OE) and Taylor's Venn-diagram, and have used Linear support vector machines as the classifier in the tests. We also have compared our method to current feature encoding scheme techniques. The tests have been carried out on comparatively large Human leukocyte antigen (HLA)-A and HLA-B allele peptide three binding datasets extracted from the Immune epitope database and analysis resource. On three datasets experimented, the IC50 cutoff a criteria is used to select the binders and non-binders peptides. Experimental results show that our amino acid encoding scheme leads to better classification performance than other amino acid encoding schemes on a standalone classifier.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21805091     DOI: 10.1007/s11010-011-1000-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  20 in total

Review 1.  SYFPEITHI: database for MHC ligands and peptide motifs.

Authors:  H Rammensee; J Bachmann; N P Emmerich; O A Bachor; S Stevanović
Journal:  Immunogenetics       Date:  1999-11       Impact factor: 2.846

Review 2.  Epitope identification and discovery using phage display libraries: applications in vaccine development and diagnostics.

Authors:  Lin-Fa Wang; Meng Yu
Journal:  Curr Drug Targets       Date:  2004-01       Impact factor: 3.465

3.  Why neural networks should not be used for HIV-1 protease cleavage site prediction.

Authors:  Thorsteinn Rögnvaldsson; Liwen You
Journal:  Bioinformatics       Date:  2004-02-26       Impact factor: 6.937

Review 4.  Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses.

Authors:  Jonathan W Yewdell
Journal:  Immunity       Date:  2006-10       Impact factor: 31.745

5.  MHCPEP, a database of MHC-binding peptides: update 1997.

Authors:  V Brusic; G Rudy; L C Harrison
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

Review 6.  MHC ligands and peptide motifs: first listing.

Authors:  H G Rammensee; T Friede; S Stevanoviíc
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

7.  Predicting MHC class I epitopes in large datasets.

Authors:  Kirsten Roomp; Iris Antes; Thomas Lengauer
Journal:  BMC Bioinformatics       Date:  2010-02-17       Impact factor: 3.169

8.  The immune epitope database and analysis resource: from vision to blueprint.

Authors:  Bjoern Peters; John Sidney; Phil Bourne; Huynh-Hoa Bui; Soeren Buus; Grace Doh; Ward Fleri; Mitch Kronenberg; Ralph Kubo; Ole Lund; David Nemazee; Julia V Ponomarenko; Muthu Sathiamurthy; Stephen Schoenberger; Scott Stewart; Pamela Surko; Scott Way; Steve Wilson; Alessandro Sette
Journal:  PLoS Biol       Date:  2005-03       Impact factor: 8.029

9.  Prediction of MHC class I binding peptides, using SVMHC.

Authors:  Pierre Dönnes; Arne Elofsson
Journal:  BMC Bioinformatics       Date:  2002-09-11       Impact factor: 3.169

10.  NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11.

Authors:  Claus Lundegaard; Kasper Lamberth; Mikkel Harndahl; Søren Buus; Ole Lund; Morten Nielsen
Journal:  Nucleic Acids Res       Date:  2008-05-07       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.